Cell culture system, its use, and cells derived therefrom

JP2025522300A5Pending Publication Date: 2026-06-03UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION
Filing Date
2023-05-24
Publication Date
2026-06-03

AI Technical Summary

Technical Problem

Current in vitro models for human embryonic development suffer from low efficiency, limited scalability, and high technical complexity, and lack systems that can support the integrated morphogenetic events of post-implantation human embryos, particularly those involving germ and extraembryonic layers.

Method used

An in vitro or ex vivo cell culture system is developed using stem cell populations with inducible transgenes for GATA6 and optionally ETV2 polypeptides, which are induced to form cell aggregates comprising embryonic and extraembryonic structures, such as bilayer disk-like structures, amnion-like domains, and yolk sac domains, through a self-organizing process.

Benefits of technology

The system effectively generates cell aggregates that mimic early human embryonic development, allowing for the study of embryonic and hematopoietic differentiation, and can be used to evaluate therapeutic agents, with reproducible formation of distinct cell structures without additional reagents.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

The present disclosure relates to a cell culture system for generating cell aggregates and its use. The cell aggregates described herein can be used for studying embryonic development and hematopoiesis and for treating diseases.
Need to check novelty before this filing date? Find Prior Art